Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220940803> ?p ?o ?g. }
- W4220940803 endingPage "71" @default.
- W4220940803 startingPage "64" @default.
- W4220940803 abstract "Abstract Dendritic cells (DC) are crucial for the priming of T cells and thereby influence adaptive immune responses. Hence, they also represent important players in shaping anti-tumour immune responses. Cancer immunotherapy has been driven over many years by the aim to harness the T-cell stimulatory activity of these crucial antigen-presenting cells (APC). Efficient antigen delivery alone is not sufficient for full engagement of the T-cell stimulatory activity of DC and the inclusion of adjuvants triggering appropriate DC activation is essential to ensure effective anti-tumour immunity induction. While the direct engagement of DC function is a powerful tool for tumour immunotherapy, many therapeutic antibodies, such as antibodies directed against tumour-associated antigens (TAA) and immune checkpoint inhibitors (ICI) have been shown to engage DC function indirectly. The induction of anti-tumour immune responses by TAA-targeting and immune checkpoint inhibitory antibodies is thought to be integral to their therapeutic efficacy. Here, we provide an overview of the immunotherapeutic antibodies in the context of cancer immunotherapy, that has been demonstrated to directly or indirectly engage DC and discuss the current understanding of the functional mechanisms underlying anti-tumour immunity induction by these antibody therapies. In the future, the combination of therapeutic strategies that engage DC function directly and/or indirectly with strategies that allow tumour infiltrating immune effector cells to exert their anti-tumour activity in the tumour microenvironment (TME) may be key for the successful treatment of cancer patients currently not responding to immunotherapeutic antibody treatment." @default.
- W4220940803 created "2022-04-03" @default.
- W4220940803 creator A5050143061 @default.
- W4220940803 creator A5073481924 @default.
- W4220940803 date "2022-03-30" @default.
- W4220940803 modified "2023-10-14" @default.
- W4220940803 title "Direct and indirect engagement of dendritic cell function by antibodies developed for cancer therapy" @default.
- W4220940803 cites W1501518736 @default.
- W4220940803 cites W1579424947 @default.
- W4220940803 cites W1652582743 @default.
- W4220940803 cites W1669165205 @default.
- W4220940803 cites W1678167583 @default.
- W4220940803 cites W1964133468 @default.
- W4220940803 cites W1976199086 @default.
- W4220940803 cites W1977016792 @default.
- W4220940803 cites W1982861708 @default.
- W4220940803 cites W1987155779 @default.
- W4220940803 cites W1995450305 @default.
- W4220940803 cites W2002761249 @default.
- W4220940803 cites W2006010160 @default.
- W4220940803 cites W2008519462 @default.
- W4220940803 cites W2021995791 @default.
- W4220940803 cites W2024914696 @default.
- W4220940803 cites W2025273503 @default.
- W4220940803 cites W2034570325 @default.
- W4220940803 cites W2036564362 @default.
- W4220940803 cites W2037945565 @default.
- W4220940803 cites W2044757050 @default.
- W4220940803 cites W2046505430 @default.
- W4220940803 cites W2048982222 @default.
- W4220940803 cites W2055021349 @default.
- W4220940803 cites W2060938552 @default.
- W4220940803 cites W2066471812 @default.
- W4220940803 cites W2066964346 @default.
- W4220940803 cites W2069891242 @default.
- W4220940803 cites W2070225034 @default.
- W4220940803 cites W2072222051 @default.
- W4220940803 cites W2075901113 @default.
- W4220940803 cites W2078376325 @default.
- W4220940803 cites W2093850817 @default.
- W4220940803 cites W2097229052 @default.
- W4220940803 cites W2101277086 @default.
- W4220940803 cites W2103118255 @default.
- W4220940803 cites W2111895656 @default.
- W4220940803 cites W2113316495 @default.
- W4220940803 cites W2114101532 @default.
- W4220940803 cites W2116763454 @default.
- W4220940803 cites W2122128994 @default.
- W4220940803 cites W2122584026 @default.
- W4220940803 cites W2137670912 @default.
- W4220940803 cites W2143523733 @default.
- W4220940803 cites W2147697783 @default.
- W4220940803 cites W2149260562 @default.
- W4220940803 cites W2157058162 @default.
- W4220940803 cites W2163196794 @default.
- W4220940803 cites W2166285267 @default.
- W4220940803 cites W2168028214 @default.
- W4220940803 cites W2173303337 @default.
- W4220940803 cites W2180091996 @default.
- W4220940803 cites W2302088846 @default.
- W4220940803 cites W2302910861 @default.
- W4220940803 cites W2341604280 @default.
- W4220940803 cites W2341719138 @default.
- W4220940803 cites W2400949262 @default.
- W4220940803 cites W2461271870 @default.
- W4220940803 cites W249403745 @default.
- W4220940803 cites W2573449099 @default.
- W4220940803 cites W2612805962 @default.
- W4220940803 cites W2625645222 @default.
- W4220940803 cites W2745792339 @default.
- W4220940803 cites W2770997251 @default.
- W4220940803 cites W2781617771 @default.
- W4220940803 cites W2785376969 @default.
- W4220940803 cites W2808909747 @default.
- W4220940803 cites W2887577080 @default.
- W4220940803 cites W2893742037 @default.
- W4220940803 cites W2896033748 @default.
- W4220940803 cites W2900717255 @default.
- W4220940803 cites W2903686952 @default.
- W4220940803 cites W2904099327 @default.
- W4220940803 cites W2936414047 @default.
- W4220940803 cites W2970536272 @default.
- W4220940803 cites W2982392853 @default.
- W4220940803 cites W2986511818 @default.
- W4220940803 cites W2994788027 @default.
- W4220940803 cites W2999281781 @default.
- W4220940803 cites W3004735927 @default.
- W4220940803 cites W3005703223 @default.
- W4220940803 cites W3011497962 @default.
- W4220940803 cites W3036599100 @default.
- W4220940803 cites W3037163580 @default.
- W4220940803 cites W3042291772 @default.
- W4220940803 cites W3089064012 @default.
- W4220940803 cites W3122174179 @default.
- W4220940803 cites W3125826904 @default.
- W4220940803 cites W3132732945 @default.
- W4220940803 cites W3153286323 @default.
- W4220940803 cites W3162648617 @default.